284 related articles for article (PubMed ID: 28361599)
21. Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.
Mody P; Sidhu MS; Brilakis ES; Sacco JD; Banerjee S; Boden WE
Cardiol Rev; 2016; 24(4):177-89. PubMed ID: 26274534
[TBL] [Abstract][Full Text] [Related]
22. Ranolazine (Ranexa) for chronic stable angina.
Ndegwa S
Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
[TBL] [Abstract][Full Text] [Related]
23. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
Hanai Y; Mita M; Hishinuma S; Shoji M
Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
[TBL] [Abstract][Full Text] [Related]
25. Conventional and novel drug therapeutics to relief myocardial ischemia.
Dvir D; Battler A
Cardiovasc Drugs Ther; 2010 Aug; 24(4):319-23. PubMed ID: 20658184
[TBL] [Abstract][Full Text] [Related]
26. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
Fox K
Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707
[TBL] [Abstract][Full Text] [Related]
27. Use of ranolazine in patients with stable angina pectoris.
Khera S; Kolte D; Aronow WS
Cardiology; 2014; 128(3):251-8. PubMed ID: 24852049
[TBL] [Abstract][Full Text] [Related]
28. The Effectiveness of Trimetazidine Treatment in Patients with Stable Angina Pectoris of Various Durations: Results from the CHOICE-2 Study.
Glezer M;
Adv Ther; 2018 Jul; 35(7):1103-1113. PubMed ID: 29766461
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents.
Jackson G
Int J Clin Pract; 2001 May; 55(4):256-61. PubMed ID: 11406911
[TBL] [Abstract][Full Text] [Related]
30. Angina and Its Management.
Kloner RA; Chaitman B
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):199-209. PubMed ID: 28196437
[TBL] [Abstract][Full Text] [Related]
31. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
Thadani U
Expert Opin Pharmacother; 2012 Dec; 13(17):2555-63. PubMed ID: 23121448
[TBL] [Abstract][Full Text] [Related]
32. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
33. Beta-Blockers and Nitrates: Pharmacotherapy and Indications.
Facchini E; Degiovanni A; Cavallino C; Lupi A; Rognoni A; Bongo AS
Cardiovasc Hematol Agents Med Chem; 2015; 13(1):25-30. PubMed ID: 25544116
[TBL] [Abstract][Full Text] [Related]
34. Medical management of myocardial ischemia.
Sander GE; Giles TD
Am J Geriatr Cardiol; 2005; 14(4):205-9. PubMed ID: 16015063
[No Abstract] [Full Text] [Related]
35. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
Deedwania PC; Carbajal EV
Am J Med; 2011 Aug; 124(8):681-8. PubMed ID: 21787900
[TBL] [Abstract][Full Text] [Related]
36. [Beta blockers in stable angina pectoris].
Fluri M; Meier B
Praxis (Bern 1994); 1995 Mar; 84(10):288-95. PubMed ID: 7892549
[TBL] [Abstract][Full Text] [Related]
37. [Therapy of angina pectoris--state of the art].
Nager F
Schweiz Rundsch Med Prax; 1990 Mar; 79(10):267-76. PubMed ID: 1969177
[TBL] [Abstract][Full Text] [Related]
38. ["Persistent" angina: rationale for a metabolic approach].
Marzilli M
Ital Heart J; 2004 Mar; 5 Suppl 2():37S-41S. PubMed ID: 15074776
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive drug management of angina pectoris.
Pepine CJ; Feldman RL; Conti CR
Cardiovasc Clin; 1984; 14(3):139-51. PubMed ID: 6144388
[TBL] [Abstract][Full Text] [Related]
40. [The choice of drugs and dosage for angina pectoris].
Follath F
Schweiz Med Wochenschr Suppl; 1984; 16():65-9. PubMed ID: 6146201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
